Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Donald Shields"'
Autor:
Van Hirtum-Das, Michele, Licht, Eliot A., Koh, Susan, Wu, Joyce Y., Donald Shields, W., Sankar, Raman
Publikováno v:
In Epilepsy Research 2006 70 Supplement:248-258
Autor:
Caplan, Rochelle, Siddarth, Prabha, Bailey, Caroline E., Lanphier, Erin K., Gurbani, Suresh, Donald Shields, W., Sankar, Raman
Publikováno v:
In Epilepsy and Behavior 2006 8(4):726-735
Autor:
Lester Hankin, Donald Shields
Publikováno v:
Journal of food protection. 46(10)
Raw cow and goat milks for retail sale in Connecticut were examined at collection and after storage at 4.4 and 7.2°C for 7 d for keeping quality, flavor, microorganisms, protein degradation on storage, and protease and lipase activity. Some milks we
Autor:
Cameron Cosgrove, Lee C. Hastie, Lorna Brown, Isabel Isherwood, Peter J. Cosgrove, Jon Watt, Miguel Bao, Donald Shields, Iain Sime
Publikováno v:
Biodiversity and Conservation. 25:2093-2112
All known rivers in Scotland with recent records of freshwater pearl mussels Margaritifera margaritifera were surveyed in 2013–2015 using a standard methodology. Freshwater pearl mussel populations were classed as: (i) apparently extinct in 11 rive
Autor:
Gregory L. Krauss, Deborah Lee, Yekaterina Dribinsky, W. Donald Shields, Rod Foroozan, Feisal Othman, John M. Pellock, Robert C. Sergott, Edward Faught, Adam Ziemann, Sarah Torri, Jouko Isojarvi
Publikováno v:
Epilepsy & Behavior. 56:15-19
Vigabatrin (Sabril®), approved in the US in 2009, is currently indicated as adjunctive therapy for refractory complex partial seizures (rCPS) in patients ≥ 10 years old who have responded inadequately to several alternative treatments and as monot
Publikováno v:
Pipelines 2018.
Autor:
Eric H. Kossoff, W. Donald Shields
Publikováno v:
Epilepsia. 55:29-33
Summary Individuals with Lennox-Gastaut syndrome (LGS) often do not respond to or become resistant to pharmacologic treatments. Ketogenic diets (KDs) and vagus nerve stimulation (VNS) are nonpharmacologic treatment options for these intractable patie
Autor:
Yekaterina Dribinsky, Adam Ziemann, Rod Foroozan, W. Donald Shields, Deborah Lee, Feisal Othman, Sarah Torri, Edward Faught, John M. Pellock, Robert C. Sergott, Jouko Isojarvi
Publikováno v:
Epilepsybehavior : EB. 60
Vigabatrin (Sabril®) is an antiepileptic drug (AED) currently indicated in the US as a monotherapy for patients 1month to 2years of age with infantile spasms (IS) and as adjunctive therapy for patients ≥10years of age with refractory complex parti
Autor:
John M. Pellock, Edward Faught, Mark A. Weinberg, Gregory A. Burkhart, Rod Foroozan, Gregory L. Krauss, W. Donald Shields, David L. Wesche, Robert C. Sergott
Publikováno v:
Epilepsy & Behavior. 22:710-717
The vigabatrin patient registry was implemented in August 2009 in conjunction with Food and Drug Administration approval of vigabatrin. All US vigabatrin-treated patients must enroll in the registry. Data on prescriber specialty/location, patient dem
Autor:
Jennifer G. Levitt, Prabha Siddarth, Pengju Benjamin Tseng, Matthew Hudkins, Ronald R. Seese, Joseph O'Neill, Suresh Gurbani, Rochelle Caplan, W. Donald Shields, Keng Nei Wu
Publikováno v:
Epilepsia. 52:1705-1714
Summary Purpose: To investigate relationships between regional brain metabolites, social communication deficits, and seizure frequency in children and adolescents with cryptogenic epilepsy with complex partial seizures (CPS). Methods: In 12 children